On the recordDecember 10, 2013
I would suggest a tainted drug is very different from a drug labeling issue.
Source
congress.govI would suggest a tainted drug is very different from a drug labeling issue.
Collins distinguishes between issues of drug safety and labeling.
Share
More from Susan Collins
While I agree these principles should guide the administration and oversight of Federal funds, the rule would impose new, burdensome requirements on award recipients … and conflict with Congress’ control over the federal funding process.
It appears that there is good faith on the Democratic side to try to pass the CR and avoid a government shutdown, which is always a disaster.
What appears to have happened is that there now has been ... somewhat of an increase of ICE activities before the additional training and body-worn cameras were deployed.